UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002863
Receipt number R000003485
Scientific Title A clinical trial of proton radiotherapy with local immunotherapy for recurrent cases with hepatocellular carcinoma
Date of disclosure of the study information 2016/12/31
Last modified on 2011/07/21 11:34:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A clinical trial of proton radiotherapy with local immunotherapy for recurrent cases with hepatocellular carcinoma

Acronym

Proton radiotherapy and immunotherapy for hepatic cancer

Scientific Title

A clinical trial of proton radiotherapy with local immunotherapy for recurrent cases with hepatocellular carcinoma

Scientific Title:Acronym

Proton radiotherapy and immunotherapy for hepatic cancer

Region

Japan


Condition

Condition

Hepatocellular Carcinoma

Classification by specialty

Hepato-biliary-pancreatic medicine Hepato-biliary-pancreatic surgery Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify the safety of a treatment consisting of proton radiotherapy and local immunotherapy for recurrent cases with hepatocellular carcinoma

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Safety
Prevention of recurrence

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Vaccine Device,equipment

Interventions/Control_1

Proton radiotherapy
Tumor immunotherapy by a novel adjuvant

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Recurrent cases with locally advanced hepatocellular carcinoma
Life expectency is 6 months or more.
Proton radiotherapy is indicated.
KPS is 60% or more.
Hepatic function is preserved.

Key exclusion criteria

Initially diagnosed case
History of having other malignancies
Having autoimmune disorders
HIV positive
Uncontrollable complications such as infections, heart disorders or psychiatric disorders
Administration of anticancer drugs or corticosteroids within 4 months
Pregnant
Tuberculosis, or hyperreaction in DTH test with the advant

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Koji Tsuboi

Organization

University of Tsukuba

Division name

Proton medical research center, Graduate School of Comprehensive Human Sciences

Zip code


Address

1-1-1, Tennodai, Tsukuba, Ibaraki 305-8575, Japan

TEL

029-853-7100

Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

University of Tsukuba

Division name

Proton Medical Research Center

Zip code


Address


TEL


Homepage URL


Email



Sponsor or person

Institute

Proton Medical Research Center, University of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

Ibaraki Prefecture

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 12 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 12 Month 20 Day

Date of IRB


Anticipated trial start date

2009 Year 12 Month 01 Day

Last follow-up date

2016 Year 12 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 12 Month 09 Day

Last modified on

2011 Year 07 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003485


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name